[23 May 2012]
Products Affected - Description
Refludan injection, Bayer HealthCare
50 mg vials, 10 count (NDC 50419-0150-57) - discontinued
Reason for the Shortage
- Bayer HealthCare will discontinue Refludan injection on May 31, 2012. This was a business decision and not due to safety concerns.
- There are no other manufacturers of lepirudin injection.
No presentations are readily available.
Estimated Resupply Dates
Bayer HealthCare will stop shipping Refludan in late-May, 2012. The company expects supply from wholesalers to be depleted by mid-2013.
May 23, 2012, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins